{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:37:22Z","timestamp":1790869042659,"version":"4.1.0"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010198","name":"Ministerio de Asuntos Econ\u00f3micos y Transformaci\u00f3n Digital, Gobierno de Espa\u00f1a","doi-asserted-by":"publisher","award":["RYC2018-024374-I"],"award-info":[{"award-number":["RYC2018-024374-I"]}],"id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RTI2018-097485-A-I00; PID2021-127899OB-I00; CNS2023-144841"],"award-info":[{"award-number":["RTI2018-097485-A-I00; PID2021-127899OB-I00; CNS2023-144841"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-138880OB-I00; PDC2021-121238-I00"],"award-info":[{"award-number":["PID2022-138880OB-I00; PDC2021-121238-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["HR20-00218"],"award-info":[{"award-number":["HR20-00218"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["HR20-00218"],"award-info":[{"award-number":["HR20-00218"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["LCF\/PR\/HR23\/52430018"],"award-info":[{"award-number":["LCF\/PR\/HR23\/52430018"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["HR20-00218"],"award-info":[{"award-number":["HR20-00218"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010434","name":"'la Caixa' Foundation","doi-asserted-by":"publisher","award":["PID2023-149541OB-I00"],"award-info":[{"award-number":["PID2023-149541OB-I00"]}],"id":[{"id":"10.13039\/100010434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["CB21\/13\/00107"],"award-info":[{"award-number":["CB21\/13\/00107"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["CB21\/13\/00107"],"award-info":[{"award-number":["CB21\/13\/00107"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["PI22\/01120"],"award-info":[{"award-number":["PI22\/01120"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["CB21\/13\/00107"],"award-info":[{"award-number":["CB21\/13\/00107"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023961","name":"Centro de Investigaci\u00f3n Biotecnol\u00f3gica en Red de Enfermedades Infecciosas","doi-asserted-by":"publisher","award":["CB21\/13\/00107"],"award-info":[{"award-number":["CB21\/13\/00107"]}],"id":[{"id":"10.13039\/501100023961","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["2017-T1\/BMD-5396"],"award-info":[{"award-number":["2017-T1\/BMD-5396"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD7209"],"award-info":[{"award-number":["P2022\/BMD7209"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"MEC | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PRE2022-104516"],"award-info":[{"award-number":["PRE2022-104516"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008799","name":"Gilead Foundation","doi-asserted-by":"publisher","award":["GLD24\/00117"],"award-info":[{"award-number":["GLD24\/00117"]}],"id":[{"id":"10.13039\/100008799","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004593","name":"Universidad Aut\u00f3noma de Madrid","doi-asserted-by":"publisher","award":["FPI UAM"],"award-info":[{"award-number":["FPI UAM"]}],"id":[{"id":"10.13039\/501100004593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,7,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Natural Killer (NK) cells are promising candidates for targeting persistently infected CD4\u2009+\u2009T cells in people with HIV-1 (PWH). However, chronicity of HIV-1 infection impairs NK cell functionality, requiring additional strategies to potentiate their cytotoxic activity. This study demonstrates that dendritic cells primed with nanoparticles containing Poly I:C (Nano-PIC-MDDC) enhance the natural cytotoxic function of NK cells from effective responder PWH. These NK cells exhibit increased proportions of NKG2C+ cell subsets capable of eliminating HIV-1 infected CD4\u2009+\u2009T cells through the TRAIL receptor. In contrast, in non-responder PWH, elevated expression of the inhibitory receptor TIGIT is associated with reduced frequencies of NKG2C\u2009+\u2009NK cells and diminished TRAIL expression. TIGIT blockade restores cytotoxicity of NK cells from non-responder PWH against HIV-1-infected cells by upregulating TRAIL. Furthermore, combining Nano-PIC-MDDC-primed NK cells with anti-TIGIT immunotherapy in humanized NSG mice reduces the expansion of HIV-1 infected cells, preserves NKG2C\u2009+\u2009NK cell precursors and increases TRAIL expression in tissue. Collectively, these findings support the combined use of Nano-PIC-MDDC and TIGIT blockade as a promising immunotherapeutic strategy toward an HIV-1 cure.<\/jats:p>","DOI":"10.1038\/s44321-025-00255-x","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T09:57:29Z","timestamp":1749117449000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1"],"prefix":"10.1038","volume":"17","author":[{"given":"Ildefonso","family":"S\u00e1nchez-Cerrillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Agudo-Lera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Tsukalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Calvet-Mirabent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"de los Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Garc\u00eda-Fraile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4597-1022","authenticated-orcid":false,"given":"Patricia","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Delgado-Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Alcain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"S\u00e1nchez-Gaona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Grau-Exp\u00f3sito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"L\u00e1zaro-D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Mu\u00f1oz-Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantzazu","family":"Alfranca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6413-3812","authenticated-orcid":false,"given":"Meritxell","family":"Genesc\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia G","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Vrbanac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1767-3944","authenticated-orcid":false,"given":"Alejandro","family":"Balazs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4427-9413","authenticated-orcid":false,"given":"Mar\u00eda Jos\u00e9","family":"Buz\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda L","family":"Toribio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda A","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"S\u00e1nchez-Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2619-6086","authenticated-orcid":false,"given":"Enrique","family":"Mart\u00edn-Gayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"255_CR1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.antiviral.2019.03.008","volume":"166","author":"E Abner","year":"2019","unstructured":"Abner E, Jordan A (2019) HIV \u2018shock and kill\u2019 therapy: In need of revision. Antivir Res 166:19\u201334","journal-title":"Antivir Res"},{"key":"255_CR2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/acsinfecdis.8b00167","volume":"5","author":"NM Abuharfeil","year":"2019","unstructured":"Abuharfeil NM, Yaseen MM, Alsheyab FM (2019) Harnessing antibody-dependent cellular cytotoxicity to control HIV-1 infection. ACS Infect Dis 5:158\u2013176","journal-title":"ACS Infect Dis"},{"key":"255_CR3","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3390\/pathogens10111517","volume":"10","author":"C Acchioni","year":"2021","unstructured":"Acchioni C, Palermo E, Sandini S, Acchioni M, Hiscott J, Sgarbanti M (2021) Fighting HIV-1 persistence: at the crossroads of \u2018Shoc-K and B-Lock\u2019. Pathogens 10:1517","journal-title":"Pathogens"},{"key":"255_CR4","doi-asserted-by":"crossref","first-page":"101881","DOI":"10.1016\/j.isci.2020.101881","volume":"24","author":"P Adams","year":"2021","unstructured":"Adams P, Fievez V, Schober R, Amand M, Iserentant G, Rutsaert S, Dessilly G, Vanham G, Hedin F, Cosma A et al (2021) CD32+CD4+ memory T cells are enriched for total HIV-1 DNA in tissues from humanized mice. iScience 24:101881","journal-title":"iScience"},{"key":"255_CR5","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/QAD.0000000000003319","volume":"36","author":"A Alrubayyi","year":"2022","unstructured":"Alrubayyi A, Rowland-Jones S, Peppa D (2022) Natural killer cells during acute HIV-1 infection: clues for HIV-1 prevention and therapy. AIDS 36:1903\u20131915","journal-title":"AIDS"},{"key":"255_CR6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3390\/v15020323","volume":"15","author":"K Alsulami","year":"2023","unstructured":"Alsulami K, Dupuy FP, Gilbert L, Messier-Peet M, Durand M, Tremblay C, Routy J-P, Bruneau J, Baril J-G, Trottier B et al (2023) The frequency and function of NKG2C+CD57+ adaptive NK cells in cytomegalovirus co-infected people living with HIV decline with duration of antiretroviral therapy. Viruses 15:323","journal-title":"Viruses"},{"key":"255_CR7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/jleuko\/qiac007","volume":"113","author":"RR Anderko","year":"2023","unstructured":"Anderko RR, Mailliard RB (2023) Mapping the interplay between NK cells and HIV: therapeutic implications. J Leukoc Biol 113:109\u2013138","journal-title":"J Leukoc Biol"},{"key":"255_CR8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fimmu.2017.00391","volume":"8","author":"A Aquino-L\u00f3pez","year":"2017","unstructured":"Aquino-L\u00f3pez A, Senyukov VV, Vlasic Z, Kleinerman ES, Lee DA (2017) Interferon gamma induces changes in natural killer (NK) cell ligand expression and alters NK cell-mediated lysis of pediatric cancer cell lines. Front Immunol 8:391","journal-title":"Front Immunol"},{"key":"255_CR9","doi-asserted-by":"crossref","first-page":"101202","DOI":"10.1016\/j.xcrm.2023.101202","volume":"4","author":"A Astorga-Gamaza","year":"2023","unstructured":"Astorga-Gamaza A, Perea D, Sanchez-Gaona N, Calvet-Mirabent M, Gallego-Cort\u00e9s A, Grau-Exp\u00f3sito J, Sanchez-Cerrillo I, Rey J, Castellv\u00ed J, Curran A et al (2023) KLRG1 expression on natural killer cells is associated with HIV persistence, and its targeting promotes the reduction of the viral reservoir. Cell Rep Med 4:101202","journal-title":"Cell Rep Med"},{"key":"255_CR10","volume":"10","author":"N Bachmann","year":"2019","unstructured":"Bachmann N, von Siebenthal C, Vongrad V, Turk T, Neumann K, Beerenwinkel N, Bogojeska J, Fellay J, Roth V, Kok YL et al (2019) Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART. Nat Commun 10:3193","journal-title":"Nat Commun"},{"key":"255_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/COH.0000000000000686","volume":"16","author":"R Banga","year":"2021","unstructured":"Banga R, Munoz O, Perreau M (2021) HIV persistence in lymph nodes. Curr Opin HIV AIDS 16:209\u2013214","journal-title":"Curr Opin HIV AIDS"},{"key":"255_CR12","doi-asserted-by":"crossref","first-page":"e00937","DOI":"10.1128\/JVI.00937-17","volume":"91","author":"A Bardhi","year":"2017","unstructured":"Bardhi A, Wu Y, Chen W, Li W, Zhu Z, Zheng JH, Wong H, Jeng E, Jones J, Ochsenbauer C et al (2017) Potent in vivo NK cell-mediated elimination of HIV-1-infected cells mobilized by a gp120-bispecific and hexavalent broadly neutralizing fusion protein. J Virol 91:e00937\u201317","journal-title":"J Virol"},{"key":"255_CR13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1086\/345957","volume":"187","author":"MA Barron","year":"2003","unstructured":"Barron MA, Blyveis N, Palmer BE, MaWhinney S, Wilson CC (2003) Influence of plasma viremia on defects in number and immunophenotype of blood dendritic cell subsets in human immunodeficiency virus 1-infected individuals. J Infect Dis 187:26\u201337","journal-title":"J Infect Dis"},{"key":"255_CR14","doi-asserted-by":"crossref","first-page":"1270881","DOI":"10.3389\/fimmu.2023.1270881","volume":"14","author":"JM Benito","year":"2023","unstructured":"Benito JM, Restrepo C, Garc\u00eda-Foncillas J, Rall\u00f3n N (2023) Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV. Front Immunol 14:1270881","journal-title":"Front Immunol"},{"key":"255_CR15","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/COH.0000000000000812","volume":"18","author":"S Bhattacharyya","year":"2023","unstructured":"Bhattacharyya S, Crain CR, Goldberg B, Gaiha GD (2023) Features of functional and dysfunctional CD8+T cells to guide HIV vaccine development. Curr Opin HIV AIDS 18:257\u2013263","journal-title":"Curr Opin HIV AIDS"},{"key":"255_CR16","doi-asserted-by":"crossref","first-page":"e83737","DOI":"10.7554\/eLife.83737","volume":"12","author":"O Blanch-Lombarte","year":"2023","unstructured":"Blanch-Lombarte O, Ouchi D, Jimenez-Moyano E, Carabelli J, Marin MA, Pe\u00f1a R, Pelletier A, Talla A, Sharma A, Dalmau J et al (2023) Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+T cells in PLWH over a decade of ART. eLife 12:e83737","journal-title":"eLife"},{"key":"255_CR17","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41590-023-01741-5","volume":"25","author":"NL Board","year":"2024","unstructured":"Board NL, Yuan Z, Wu F, Moskovljevic M, Ravi M, Sengupta S, Mun SS, Simonetti FR, Lai J, Tebas P et al (2024) Bispecific antibodies promote natural killer cell-mediated elimination of HIV-1 reservoir cells. Nat Immunol 25:462\u2013470","journal-title":"Nat Immunol"},{"key":"255_CR18","doi-asserted-by":"crossref","first-page":"631713","DOI":"10.3389\/fimmu.2020.631713","volume":"11","author":"J B\u00f6dder","year":"2020","unstructured":"B\u00f6dder J, Zahan T, van Slooten R, Schreibelt G, de Vries IJM, Fl\u00f3rez-Grau G (2020) Harnessing the cDC1-NK cross-talk in the tumor microenvironment to battle cancer. Front Immunol 11:631713","journal-title":"Front Immunol"},{"key":"255_CR19","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1128\/JVI.02207-08","volume":"83","author":"DM Brainard","year":"2009","unstructured":"Brainard DM, Seung E, Frahm N, Cariappa A, Bailey CC, Hart WK, Shin H-S, Brooks SF, Knight HL, Eichbaum Q et al (2009) Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice. J Virol 83:7305\u20137321","journal-title":"J Virol"},{"key":"255_CR20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","volume":"566","author":"KM Bruner","year":"2019","unstructured":"Bruner KM, Wang Z, Simonetti FR, Bender AM, Kwon KJ, Sengupta S, Fray EJ, Beg SA, Antar AAR, Jenike KM et al (2019) A quantitative approach for measuring the reservoir of latent HIV-1 proviruses. Nature 566:120\u2013125","journal-title":"Nature"},{"key":"255_CR21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/COH.0000000000000750","volume":"17","author":"M Calvet-Mirabent","year":"2022","unstructured":"Calvet-Mirabent M, Mart\u00edn-Gayo E (2022) Effective innate immune response in natural HIV-1 controllers. Can mimicking lead to novel preventive and cure strategies against HIV-1? Curr Opin HIV AIDS 17:308\u2013314","journal-title":"Curr Opin HIV AIDS"},{"key":"255_CR22","doi-asserted-by":"crossref","first-page":"104090","DOI":"10.1016\/j.ebiom.2022.104090","volume":"81","author":"M Calvet-Mirabent","year":"2022","unstructured":"Calvet-Mirabent M, S\u00e1nchez-Cerrillo I, Mart\u00edn-C\u00f3freces N, Mart\u00ednez-Fleta P, de la Fuente H, Tsukalov I, Delgado-Ar\u00e9valo C, Calzada MJ, de Los Santos I, Sanz J et al (2022) Antiretroviral therapy duration and immunometabolic state determine efficacy of ex vivo dendritic cell-based treatment restoring functional HIV-specific CD8+T cells in people living with HIV. EBioMedicine 81:104090","journal-title":"EBioMedicine"},{"key":"255_CR23","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/JLB.4MR0422-636R","volume":"112","author":"GR Campbell","year":"2022","unstructured":"Campbell GR, Spector SA (2022) Current strategies to induce selective killing of HIV-1-infected cells. J Leukoc Biol 112:1273\u20131284","journal-title":"J Leukoc Biol"},{"key":"255_CR24","doi-asserted-by":"crossref","first-page":"e0173022","DOI":"10.1128\/jvi.01730-22","volume":"96","author":"AP Chandrasekar","year":"2022","unstructured":"Chandrasekar AP, Cummins NW, Natesampillai S, Misra A, Alto A, Laird G, Badley AD (2022) The BCL-2 inhibitor venetoclax augments immune effector function mediated by Fas ligand, TRAIL, and Perforin\/Granzyme B, Resulting in reduced plasma viremia and decreased HIV reservoir size during acute HIV infection in a humanized mouse model. J Virol 96:e0173022","journal-title":"J Virol"},{"key":"255_CR25","doi-asserted-by":"crossref","first-page":"e135344","DOI":"10.1172\/jci.insight.135344","volume":"5","author":"L Cheng","year":"2020","unstructured":"Cheng L, Yu H, Wrobel JA, Li G, Liu P, Hu Z, Xu X-N, Su L (2020) Identification of pathogenic TRAIL-expressing innate immune cells during HIV-1 infection in humanized mice by scRNA-Seq. JCI Insight 5:e135344","journal-title":"JCI Insight"},{"key":"255_CR26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2174\/157016208786501472","volume":"6","author":"A Chung","year":"2008","unstructured":"Chung A, Rollman E, Johansson S, Kent SJ, Stratov I (2008) The utility of ADCC responses in HIV infection. Curr HIV Res 6:515\u2013519","journal-title":"Curr HIV Res"},{"key":"255_CR27","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S2352-3018(22)00302-2","volume":"10","author":"N Climent","year":"2023","unstructured":"Climent N, Ambrosioni J, Gonz\u00e1lez T, Xufr\u00e9 C, Casadell\u00e0 M, Noguera-Julian M, Paredes R, Plana M, Grau-Exp\u00f3sito J, Mallolas J et al (2023) Immunological and virological findings in a patient with exceptional post-treatment control: a case report. Lancet HIV 10:e42\u2013e51","journal-title":"Lancet HIV"},{"key":"255_CR28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.it.2003.10.012","volume":"25","author":"MA Cooper","year":"2004","unstructured":"Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA (2004) NK cell and DC interactions. Trends Immunol 25:47\u201352","journal-title":"Trends Immunol"},{"key":"255_CR29","doi-asserted-by":"crossref","first-page":"e169028","DOI":"10.1172\/jci.insight.169028","volume":"8","author":"DC Copertino","year":"2023","unstructured":"Copertino DC, Holmberg CS, Weiler J, Ward AR, Howard JN, Levinger C, Pang AP, Corley MJ, D\u00fcndar F, Zumbo P et al (2023) The latency-reversing agent HODHBt synergizes with IL-15 to enhance cytotoxic function of HIV-specific T cells. JCI Insight 8:e169028","journal-title":"JCI Insight"},{"key":"255_CR30","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/QAD.0000000000003881","volume":"38","author":"TA Crowell","year":"2024","unstructured":"Crowell TA, Ritz J, Zheng L, Naqvi A, Cyktor JC, Puleo J, Clagett B, Lama JR, Kanyama C, Little SJ et al (2024) Impact of antiretroviral therapy during acute or early HIV infection on virologic and immunologic outcomes: results from a multinational clinical trial. AIDS 38:1141\u20131152","journal-title":"AIDS"},{"key":"255_CR31","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/JLB.MR0618-224RR","volume":"105","author":"ME Cruz-Mu\u00f1oz","year":"2019","unstructured":"Cruz-Mu\u00f1oz ME, Valenzuela-V\u00e1zquez L, S\u00e1nchez-Herrera J, Santa-Olalla Tapia J (2019) From the \u2018missing self\u2019 hypothesis to adaptive NK cells: insights of NK cell-mediated effector functions in immune surveillance. J Leukoc Biol 105:955\u2013971","journal-title":"J Leukoc Biol"},{"key":"255_CR32","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1002\/eji.201747060","volume":"47","author":"A Damouche","year":"2017","unstructured":"Damouche A, Pourcher G, Pourcher V, Benoist S, Busson E, Lataillade J-J, Le Van M, Lazure T, Adam J, Favier B et al (2017) High proportion of PD-1-expressing CD4+T cells in adipose tissue constitutes an immunomodulatory microenvironment that may support HIV persistence. Eur J Immunol 47:2113\u20132123","journal-title":"Eur J Immunol"},{"key":"255_CR33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.omtn.2023.05.019","volume":"32","author":"C Del Toro Runzer","year":"2023","unstructured":"Del Toro Runzer C, Anand S, Mota C, Moroni L, Plank C, van Griensven M, Balmayor ER (2023) Cellular uptake of modified mRNA occurs via caveolae-mediated endocytosis, yielding high protein expression in slow-dividing cells. Mol Ther Nucleic Acids 32:960\u2013979","journal-title":"Mol Ther Nucleic Acids"},{"key":"255_CR34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3390\/v15020440","volume":"15","author":"MC Dos Santos Guedes","year":"2023","unstructured":"Dos Santos Guedes MC, Carvalho-Silva WHV, Andrade-Santos JL, Brelaz-de-Castro MCA, Souto FO, Guimar\u00e3es RL (2023) Thymic exhaustion and increased immune activation are the main mechanisms involved in impaired immunological recovery of HIV-positive patients under ART. Viruses 15:440","journal-title":"Viruses"},{"key":"255_CR35","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1016\/S2352-3018(24)00247-9","volume":"12","author":"S Edupuganti","year":"2025","unstructured":"Edupuganti S, Hurt CB, Stephenson KE, Huang Y, Paez CA, Yu C, Yen C, Hanscom B, He Z, Miner MD et al (2025) Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136\/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial. Lancet HIV 12:e13\u2013e25","journal-title":"Lancet HIV"},{"key":"255_CR36","doi-asserted-by":"crossref","first-page":"e2218960120","DOI":"10.1073\/pnas.2218960120","volume":"120","author":"B Etemad","year":"2023","unstructured":"Etemad B, Sun X, Li Y, Melberg M, Moisi D, Gottlieb R, Ahmed H, Aga E, Bosch RJ, Acosta EP et al (2023) HIV post-treatment controllers have distinct immunological and virological features. Proc Natl Acad Sci USA 120:e2218960120","journal-title":"Proc Natl Acad Sci USA"},{"key":"255_CR37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/imr.12823","volume":"292","author":"C Fenwick","year":"2019","unstructured":"Fenwick C, Joo V, Jacquier P, Noto A, Banga R, Perreau M, Pantaleo G (2019) T-cell exhaustion in HIV infection. Immunol Rev 292:149\u2013163","journal-title":"Immunol Rev"},{"key":"255_CR38","doi-asserted-by":"crossref","first-page":"e02051","DOI":"10.1128\/JVI.02051-18","volume":"93","author":"NC Flerin","year":"2019","unstructured":"Flerin NC, Bardhi A, Zheng JH, Korom M, Folkvord J, Kovacs C, Benko E, Truong R, Mota T, Connick E et al (2019) Establishment of a novel humanized mouse model to investigate in vivo activation and depletion of patient-derived HIV latent reservoirs. J Virol 93:e02051\u201318","journal-title":"J Virol"},{"key":"255_CR39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/COH.0000000000000802","volume":"18","author":"GS Frattari","year":"2023","unstructured":"Frattari GS, Caskey M, S\u00f8gaard OS (2023) Broadly neutralizing antibodies for HIV treatment and cure approaches. Curr Opin HIV AIDS 18:157\u2013163","journal-title":"Curr Opin HIV AIDS"},{"key":"255_CR40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/infdis\/jiq077","volume":"203","author":"F Garc\u00eda","year":"2011","unstructured":"Garc\u00eda F, Climent N, Assoumou L, Gil C, Gonz\u00e1lez N, Alcam\u00ed J, Le\u00f3n A, Romeu J, Dalmau J, Mart\u00ednez-Picado J et al (2011) A therapeutic dendritic cell-based vaccine for HIV-1 infection. J Infect Dis 203:473\u2013478","journal-title":"J Infect Dis"},{"key":"255_CR41","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12094-018-1981-6","volume":"21","author":"M Gonzalez-Cao","year":"2019","unstructured":"Gonzalez-Cao M, Martinez-Picado J, Karachaliou N, Rosell R, Meyerhans A (2019) Cancer immunotherapy of patients with HIV infection. Clin Transl Oncol 21:713\u2013720","journal-title":"Clin Transl Oncol"},{"key":"255_CR42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/COH.0000000000000840","volume":"19","author":"P Grasberger","year":"2024","unstructured":"Grasberger P, Sondrini AR, Clayton KL (2024) Harnessing immune cells to eliminate HIV reservoirs. Curr Opin HIV AIDS 19:62\u201368","journal-title":"Curr Opin HIV AIDS"},{"key":"255_CR43","doi-asserted-by":"crossref","first-page":"1284293","DOI":"10.3389\/fimmu.2023.1284293","volume":"14","author":"L Guo","year":"2023","unstructured":"Guo L, Liu X, Su X (2023) The role of TEMRA cell-mediated immune senescence in the development and treatment of HIV disease. Front Immunol 14:1284293","journal-title":"Front Immunol"},{"key":"255_CR44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/bs.ai.2016.10.001","volume":"133","author":"Q Hammer","year":"2017","unstructured":"Hammer Q, Romagnani C (2017) About training and memory: NK-cell adaptation to viral infections. Adv Immunol 133:171\u2013207","journal-title":"Adv Immunol"},{"key":"255_CR45","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/14760584.2019.1675518","volume":"18","author":"T Hanke","year":"2019","unstructured":"Hanke T (2019) Aiming for protective T-cell responses: a focus on the first generation conserved-region HIVconsv vaccines in preventive and therapeutic clinical trials. Expert Rev Vaccines 18:1029\u20131041","journal-title":"Expert Rev Vaccines"},{"key":"255_CR46","doi-asserted-by":"crossref","first-page":"e54133","DOI":"10.15252\/embr.202154133","volume":"23","author":"J H\u00f6fle","year":"2022","unstructured":"H\u00f6fle J, Trenkner T, Kleist N, Schwane V, Vollmers S, Barcelona B, Niehrs A, Fittje P, Huynh-Tran VH, Sauter J et al (2022) Engagement of TRAIL triggers degranulation and IFN\u03b3 production in human natural killer cells. EMBO Rep 23:e54133","journal-title":"EMBO Rep"},{"key":"255_CR47","doi-asserted-by":"crossref","first-page":"e1348","DOI":"10.1002\/cti2.1348","volume":"10","author":"KA Holder","year":"2021","unstructured":"Holder KA, Burt K, Grant MD (2021) TIGIT blockade enhances NK cell activity against autologous HIV-1-infected CD4+T cells. Clin Transl Immunol 10:e1348","journal-title":"Clin Transl Immunol"},{"key":"255_CR48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fcimb.2020.00175","volume":"10","author":"KA Holder","year":"2020","unstructured":"Holder KA, Grant MD (2020) TIGIT blockade: a multipronged approach to target the HIV reservoir. Front Cell Infect Microbiol 10:175","journal-title":"Front Cell Infect Microbiol"},{"key":"255_CR49","doi-asserted-by":"crossref","first-page":"e0205323","DOI":"10.1128\/mbio.02053-23","volume":"14","author":"N Ikeogu","year":"2023","unstructured":"Ikeogu N, Ajibola O, Zayats R, Murooka TT (2023) Identifying physiological tissue niches that support the HIV reservoir in T cells. mBio 14:e0205323","journal-title":"mBio"},{"key":"255_CR50","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3389\/fimmu.2018.01042","volume":"9","author":"R Iwabuchi","year":"2018","unstructured":"Iwabuchi R, Ikeno S, Kobayashi-Ishihara M, Takeyama H, Ato M, Tsunetsugu-Yokota Y, Terahara K (2018) Introduction of human Flt3-L and GM-CSF into humanized mice enhances the reconstitution and maturation of myeloid dendritic cells and the development of Foxp3+CD4+T Cells. Front Immunol 9:1042","journal-title":"Front Immunol"},{"key":"255_CR51","doi-asserted-by":"crossref","first-page":"670540","DOI":"10.3389\/fimmu.2021.670540","volume":"12","author":"B Jacobs","year":"2021","unstructured":"Jacobs B, Gebel V, Heger L, Gr\u00e8ze V, Schild H, Dudziak D, Ullrich E (2021) Characterization and manipulation of the crosstalk between dendritic and natural killer cells within the tumor microenvironment. Front Immunol 12:670540","journal-title":"Front Immunol"},{"key":"255_CR52","doi-asserted-by":"crossref","first-page":"eadi3974","DOI":"10.1126\/sciimmunol.adi3974","volume":"8","author":"S Jost","year":"2023","unstructured":"Jost S, Lucar O, Lee E, Yoder T, Kroll K, Sugawara S, Smith S, Jones R, Tweet G, Werner A et al (2023) Antigen-specific memory NK cell responses against HIV and influenza use the NKG2\/HLA-E axis. Sci Immunol 8:eadi3974","journal-title":"Sci Immunol"},{"key":"255_CR53","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00262-016-1803-z","volume":"65","author":"H Kared","year":"2016","unstructured":"Kared H, Martelli S, Ng TP, Pender SLF, Larbi A (2016) CD57 in human natural killer cells and T-lymphocytes. Cancer Immunol Immunother 65:441\u2013452","journal-title":"Cancer Immunol Immunother"},{"key":"255_CR54","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/s41423-023-01071-4","volume":"20","author":"AUH Khan","year":"2023","unstructured":"Khan AUH, Ali AK, Marr B, Jo D, Ahmadvand S, Fong-McMaster C, Almutairi SM, Wang L, Sad S, Harper M-E et al (2023) The TNF\u03b1\/TNFR2 axis mediates natural killer cell proliferation by promoting aerobic glycolysis. Cell Mol Immunol 20:1140\u20131155","journal-title":"Cell Mol Immunol"},{"key":"255_CR55","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.3390\/microorganisms11081984","volume":"11","author":"JT Kim","year":"2023","unstructured":"Kim JT, Bresson-Tan G, Zack JA (2023) Current advances in humanized mouse models for studying NK cells and HIV infection. Microorganisms 11:1984","journal-title":"Microorganisms"},{"key":"255_CR56","doi-asserted-by":"crossref","first-page":"e165620","DOI":"10.1172\/JCI165620","volume":"132","author":"JT Kim","year":"2022","unstructured":"Kim JT, Zack JA (2022) A humanized mouse model to study NK cell biology during HIV infection. J Clin Investig 132:e165620","journal-title":"J Clin Investig"},{"key":"255_CR57","volume":"12","author":"NN Kinloch","year":"2021","unstructured":"Kinloch NN, Ren Y, Alberto WDC, Dong W, Khadka P, Huang SH, Mota TM, Wilson A, Shahid A, Kirkby D et al (2021) Author Correction: HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA). Nat Commun 12:2958","journal-title":"Nat Commun"},{"key":"255_CR58","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1002\/JLB.1MA0720-654RR","volume":"108","author":"PA Kobyzeva","year":"2020","unstructured":"Kobyzeva PA, Streltsova MA, Erokhina SA, Kanevskiy LM, Telford WG, Sapozhnikov AM, Kovalenko EI (2020) CD56dim CD57- NKG2C+NK cells retaining proliferative potential are possible precursors of CD57+NKG2C+ memory-like NK cells. J Leukoc Biol 108:1379\u20131395","journal-title":"J Leukoc Biol"},{"key":"255_CR59","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-42888-3","volume":"13","author":"J Kopycinski","year":"2023","unstructured":"Kopycinski J, Yang H, Hancock G, Pace M, Kim E, Frater J, St\u00f6hr W, Hanke T, Fidler S, Dorrell L et al (2023) Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions. Sci Rep 13:17155","journal-title":"Sci Rep"},{"key":"255_CR60","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/v12010037","volume":"12","author":"J Kristoff","year":"2019","unstructured":"Kristoff J, Rinaldo CR, Mailliard RB (2019) Role of dendritic cells in exposing latent HIV-1 for the kill. Viruses 12:37","journal-title":"Viruses"},{"key":"255_CR61","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1002\/eji.200635901","volume":"36","author":"ML LaBonte","year":"2006","unstructured":"LaBonte ML, McKay PF, Letvin NL (2006) Evidence of NK cell dysfunction in SIV-infected rhesus monkeys: impairment of cytokine secretion and NKG2C\/C2 expression. Eur J Immunol 36:2424\u20132433","journal-title":"Eur J Immunol"},{"key":"255_CR62","doi-asserted-by":"crossref","first-page":"1505840","DOI":"10.3389\/fimmu.2024.1505840","volume":"15","author":"F Lagu\u00eda","year":"2024","unstructured":"Lagu\u00eda F, Chojnacki J, Erkizia I, Geli MI, Enrich C, Martinez-Picado J, Resa-Infante P (2024) Massive endocytosis mechanisms are involved in uptake of HIV-1 particles by monocyte-derived dendritic cells. Front Immunol 15:1505840","journal-title":"Front Immunol"},{"key":"255_CR63","doi-asserted-by":"crossref","first-page":"eadg3868","DOI":"10.1126\/sciimmunol.adg3868","volume":"8","author":"X Lan","year":"2023","unstructured":"Lan X, Zebley CC, Youngblood B (2023) Cellular and molecular waypoints along the path of T cell exhaustion. Sci Immunol 8:eadg3868","journal-title":"Sci Immunol"},{"key":"255_CR64","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4014\/jmb.2304.04023","volume":"33","author":"HH Lee","year":"2023","unstructured":"Lee HH, Kang H, Cho H (2023) Role of interleukin(IL)-6 in NK activity to hypoxic-induced highly invasive hepatocellular carcinoma (HCC) cells. J Microbiol Biotechnol 33:864\u2013874","journal-title":"J Microbiol Biotechnol"},{"key":"255_CR65","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/eji.201344433","volume":"44","author":"Y L\u00e9vy","year":"2014","unstructured":"L\u00e9vy Y, Thi\u00e9baut R, Montes M, Lacabaratz C, Sloan L, King B, P\u00e9rusat S, Harrod C, Cobb A, Roberts LK et al (2014) Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load. Eur J Immunol 44:2802\u20132810","journal-title":"Eur J Immunol"},{"key":"255_CR66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/infdis\/jiaa681","volume":"223","author":"C Li","year":"2021","unstructured":"Li C, Mori L, Valente ST (2021) The block-and-lock strategy for human immunodeficiency virus cure: lessons learned from didehydro-cortistatin A. J Infect Dis 223:46\u201353","journal-title":"J Infect Dis"},{"key":"255_CR67","volume":"12","author":"Q Lin","year":"2021","unstructured":"Lin Q, Rong L, Jia X, Li R, Yu B, Hu J, Luo X, Badea SR, Xu C, Fu G et al (2021) IFN-\u03b3-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella. Nat Commun 12:2537","journal-title":"Nat Commun"},{"key":"255_CR68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12985-019-1276-8","volume":"17","author":"R Liu","year":"2020","unstructured":"Liu R, Simonetti FR, Ho Y-C (2020) The forces driving clonal expansion of the HIV-1 latent reservoir. Virol J 17:4","journal-title":"Virol J"},{"key":"255_CR69","first-page":"E11341","volume":"115","author":"C-L Lu","year":"2018","unstructured":"Lu C-L, Pai JA, Nogueira L, Mendoza P, Gruell H, Oliveira TY, Barton J, Lorenzi JCC, Cohen YZ, Cohn LB et al (2018) Relationship between intact HIV-1 proviruses in circulating CD4+T cells and rebound viruses emerging during treatment interruption. Proc Natl Acad Sci USA 115:E11341\u2013E11348","journal-title":"Proc Natl Acad Sci USA"},{"key":"255_CR70","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","volume":"10","author":"W Lu","year":"2004","unstructured":"Lu W, Arraes LC, Ferreira WT, Andrieu J-M (2004) Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat Med 10:1359\u20131365","journal-title":"Nat Med"},{"key":"255_CR71","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3389\/fimmu.2019.01850","volume":"10","author":"O Lucar","year":"2019","unstructured":"Lucar O, Reeves RK, Jost S (2019) A natural impact: NK cells at the intersection of cancer and HIV disease. Front Immunol 10:1850","journal-title":"Front Immunol"},{"key":"255_CR72","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3389\/fimmu.2017.01176","volume":"8","author":"M Ma","year":"2017","unstructured":"Ma M, Wang Z, Chen X, Tao A, He L, Fu S, Zhang Z, Fu Y, Guo C, Liu J et al (2017) NKG2C+NKG2A- natural killer cells are associated with a lower viral set point and may predict disease progression in individuals with primary HIV infection. Front Immunol 8:1176","journal-title":"Front Immunol"},{"key":"255_CR73","doi-asserted-by":"crossref","first-page":"e0037222","DOI":"10.1128\/jvi.00372-22","volume":"96","author":"AB Macedo","year":"2022","unstructured":"Macedo AB, Levinger C, Nguyen BN, Richard J, Gupta M, Cruz CRY, Finzi A, Chiappinelli KB, Crandall KA, Bosque A (2022) The HIV latency reversal agent HODHBt enhances NK Cell effector and memory-like functions by increasing interleukin-15-mediated STAT activation. J Virol 96:e0037222","journal-title":"J Virol"},{"key":"255_CR74","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/cells13050451","volume":"13","author":"A Maia","year":"2024","unstructured":"Maia A, Tarannum M, L\u00e9rias JR, Piccinelli S, Borrego LM, Maeurer M, Romee R, Castillo-Martin M (2024) Building a better defense: expanding and improving natural killer cells for adoptive cell therapy. Cells 13:451","journal-title":"Cells"},{"key":"255_CR75","doi-asserted-by":"crossref","first-page":"e1011725","DOI":"10.1371\/journal.ppat.1011725","volume":"19","author":"A Malyshkina","year":"2023","unstructured":"Malyshkina A, Bayer W, Podschwadt P, Otto L, Karakoese Z, Sutter K, Bruderek K, Wang B, Lavender KJ, Santiago ML et al (2023) Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles. PLoS Pathog 19:e1011725","journal-title":"PLoS Pathog"},{"key":"255_CR76","doi-asserted-by":"crossref","first-page":"e00647","DOI":"10.1128\/JVI.00647-17","volume":"91","author":"F Marras","year":"2017","unstructured":"Marras F, Casabianca A, Bozzano F, Ascierto ML, Orlandi C, Di Biagio A, Pontali E, Dentone C, Orofino G, Nicolini L et al (2017) Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46\/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells. J Virol 91:e00647\u201317","journal-title":"J Virol"},{"key":"255_CR77","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1128\/JVI.05788-11","volume":"86","author":"G Matusali","year":"2012","unstructured":"Matusali G, Potest\u00e0 M, Santoni A, Cerboni C, Doria M (2012) The human immunodeficiency virus type 1 Nef and Vpu proteins downregulate the natural killer cell-activating ligand PVR. J Virol 86:4496\u20134504","journal-title":"J Virol"},{"key":"255_CR78","doi-asserted-by":"crossref","first-page":"e00755","DOI":"10.1128\/JVI.00755-20","volume":"94","author":"JB McBrien","year":"2020","unstructured":"McBrien JB, Wong AKH, White E, Carnathan DG, Lee JH, Safrit JT, Vanderford TH, Paiardini M, Chahroudi A, Silvestri G (2020) Combination of CD8\u03b2 depletion and interleukin-15 superagonist N-803 induces virus reactivation in simian-human immunodeficiency virus-infected, long-term ART-treated Rhesus macaques. J Virol 94:e00755\u201320","journal-title":"J Virol"},{"key":"255_CR79","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/jiv230","volume":"212","author":"KA Metcalf Pate","year":"2015","unstructured":"Metcalf Pate KA, Pohlmeyer CW, Walker-Sperling VE, Foote JB, Najarro KM, Cryer CG, Salgado M, Gama L, Engle EL, Shirk EN et al (2015) A murine viral outgrowth assay to detect residual HIV type 1 in patients with undetectable viral loads. J Infect Dis 212:1387\u20131396","journal-title":"J Infect Dis"},{"key":"255_CR80","doi-asserted-by":"crossref","first-page":"104987","DOI":"10.1016\/j.ebiom.2024.104987","volume":"100","author":"MD Miner","year":"2024","unstructured":"Miner MD, deCamp A, Grunenberg N, De Rosa SC, Fiore-Gartland A, Bar K, Spearman P, Allen M, Yu P-C, Manso B et al (2024) Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial. EBioMedicine 100:104987","journal-title":"EBioMedicine"},{"key":"255_CR81","doi-asserted-by":"crossref","first-page":"9470102","DOI":"10.1155\/2020\/9470102","volume":"2020","author":"H Mohamed","year":"2020","unstructured":"Mohamed H, Miller V, Jennings SR, Wigdahl B, Krebs FC (2020) The evolution of dendritic cell immunotherapy against HIV-1 infection: improvements and outlook. J Immunol Res 2020:9470102","journal-title":"J Immunol Res"},{"key":"255_CR82","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3390\/v15122385","volume":"15","author":"N Mohammadzadeh","year":"2023","unstructured":"Mohammadzadeh N, Chomont N, Estaquier J, Cohen EA, Power C (2023) Is the central nervous system reservoir a hurdle for an HIV cure? Viruses 15:2385","journal-title":"Viruses"},{"key":"255_CR83","doi-asserted-by":"crossref","first-page":"e173099","DOI":"10.1172\/jci.insight.173099","volume":"9","author":"E Moreno-Cubero","year":"2024","unstructured":"Moreno-Cubero E, Alrubayyi A, Balint S, Ogbe A, Gill US, Matthews R, Kinloch S, Burns F, Rowland-Jones SL, Borrow P et al (2024) IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection. JCI Insight 9:e173099","journal-title":"JCI Insight"},{"key":"255_CR84","doi-asserted-by":"crossref","first-page":"e0286507","DOI":"10.1371\/journal.pone.0286507","volume":"18","author":"A Moyano","year":"2023","unstructured":"Moyano A, Ndlovu B, Mbele M, Naidoo K, Khan N, Mann JK, Ndung\u2019u T (2023) Differing natural killer cell, T cell and antibody profiles in antiretroviral-naive HIV-1 viraemic controllers with and without protective HLA alleles. PLoS ONE 18:e0286507","journal-title":"PLoS ONE"},{"key":"255_CR85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/v16020219","volume":"16","author":"W Mu","year":"2024","unstructured":"Mu W, Patankar V, Kitchen S, Zhen A (2024) Examining chronic inflammation, immune metabolism, and T cell dysfunction in HIV infection. Viruses 16:219","journal-title":"Viruses"},{"key":"255_CR86","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1093\/infdis\/jiw636","volume":"215","author":"JI Mullins","year":"2017","unstructured":"Mullins JI, Frenkel LM (2017) Clonal expansion of human immunodeficiency virus-infected cells and human immunodeficiency virus persistence during antiretroviral therapy. J Infect Dis 215:S119\u2013S127","journal-title":"J Infect Dis"},{"key":"255_CR87","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/eji.201243117","volume":"43","author":"A Muntasell","year":"2013","unstructured":"Muntasell A, Vilches C, Angulo A, L\u00f3pez-Botet M (2013) Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur J Immunol 43:1133\u20131141","journal-title":"Eur J Immunol"},{"key":"255_CR88","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1007\/s00018-015-2005-0","volume":"72","author":"M O\u2019Keeffe","year":"2015","unstructured":"O\u2019Keeffe M, Mok WH, Radford KJ (2015) Human dendritic cell subsets and function in health and disease. Cell Mol Life Sci 72:4309\u20134325","journal-title":"Cell Mol Life Sci"},{"key":"255_CR89","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.4049\/jimmunol.1900792","volume":"203","author":"AA Okoye","year":"2019","unstructured":"Okoye AA, DeGottardi MQ, Fukazawa Y, Vaidya M, Abana CO, Konfe AL, Fachko DN, Duell DM, Li H, Lum R et al (2019) Role of IL-15 signaling in the pathogenesis of simian immunodeficiency virus infection in Rhesus macaques. J Immunol 203:2928\u20132943","journal-title":"J Immunol"},{"key":"255_CR90","doi-asserted-by":"crossref","first-page":"13326","DOI":"10.3390\/ijms222413326","volume":"22","author":"AI Palamarchuk","year":"2021","unstructured":"Palamarchuk AI, Alekseeva NA, Streltsova MA, Ustiuzhanina MO, Kobyzeva PA, Kust SA, Grechikhina MV, Boyko AA, Shustova OA, Sapozhnikov AM et al (2021) Increased susceptibility of the CD57- NK cells expressing KIR2DL2\/3 and NKG2C to iCasp9 gene retroviral transduction and the relationships with proliferative potential, activation degree, and death induction response. Int J Mol Sci 22:13326","journal-title":"Int J Mol Sci"},{"key":"255_CR91","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4049\/jimmunol.1801511","volume":"203","author":"E Papasavvas","year":"2019","unstructured":"Papasavvas E, Azzoni L, Kossenkov AV, Dawany N, Morales KH, Fair M, Ross BN, Lynn K, Mackiewicz A, Mounzer K et al (2019) NK response correlates with HIV decrease in pegylated IFN-\u03b12a-treated antiretroviral therapy-suppressed subjects. J Immunol 203:705\u2013717","journal-title":"J Immunol"},{"key":"255_CR92","doi-asserted-by":"crossref","first-page":"621254","DOI":"10.3389\/fimmu.2020.621254","volume":"11","author":"EE Peterson","year":"2020","unstructured":"Peterson EE, Barry KC (2020) The natural killer-dendritic cell immune axis in anti-cancer immunity and immunotherapy. Front Immunol 11:621254","journal-title":"Front Immunol"},{"key":"255_CR93","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.celrep.2019.10.094","volume":"29","author":"TNQ Pham","year":"2019","unstructured":"Pham TNQ, Meziane O, Miah MA, Volodina O, Colas C, B\u00e9land K, Li Y, Dallaire F, Keler T, Guimond JV et al (2019) Flt3L-mediated expansion of plasmacytoid dendritic cells suppresses HIV infection in humanized mice. Cell Rep 29:2770\u20132782.e5","journal-title":"Cell Rep"},{"key":"255_CR94","doi-asserted-by":"crossref","first-page":"9426","DOI":"10.3390\/ijms23169426","volume":"23","author":"M-TT Phan","year":"2022","unstructured":"Phan M-TT, Kim J, Koh SK, Lim Y, Yu H, Lee M, Lee J-M, Kang E-S, Kim H-Y, Kim S-K et al (2022) Selective expansion of NKG2C+ adaptive NK cells using K562 cells expressing HLA-E. Int J Mol Sci 23:9426","journal-title":"Int J Mol Sci"},{"key":"255_CR95","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/COH.0000000000000836","volume":"19","author":"DKJ Pieren","year":"2024","unstructured":"Pieren DKJ, Ben\u00edtez-Mart\u00ednez A, Genesc\u00e0 M (2024) Targeting HIV persistence in the tissue. Curr Opin HIV AIDS 19:69\u201378","journal-title":"Curr Opin HIV AIDS"},{"key":"255_CR96","doi-asserted-by":"crossref","first-page":"e01790","DOI":"10.1128\/JVI.01790-18","volume":"93","author":"CW Pohlmeyer","year":"2019","unstructured":"Pohlmeyer CW, Gonzalez VD, Irrinki A, Ramirez RN, Li L, Mulato A, Murry JP, Arvey A, Hoh R, Deeks SG et al (2019) Identification of NK cell subpopulations that differentiate HIV-infected subject cohorts with diverse levels of virus control. J Virol 93:e01790\u201318","journal-title":"J Virol"},{"key":"255_CR97","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/JLB.MR0718-269R","volume":"105","author":"I Prager","year":"2019","unstructured":"Prager I, Watzl C (2019) Mechanisms of natural killer cell-mediated cellular cytotoxicity. J Leukoc Biol 105:1319\u20131329","journal-title":"J Leukoc Biol"},{"key":"255_CR98","doi-asserted-by":"crossref","first-page":"571S","DOI":"10.1177\/19476035211047627","volume":"13","author":"K Rajagopal","year":"2021","unstructured":"Rajagopal K, Arjunan P, Marepally S, Madhuri V (2021) Controlled differentiation of mesenchymal stem cells into hyaline cartilage in miR-140-activated collagen hydrogel. Cartilage 13:571S\u2013581S","journal-title":"Cartilage"},{"key":"255_CR99","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3389\/fimmu.2020.01676","volume":"11","author":"DR Ram","year":"2020","unstructured":"Ram DR, Arias CF, Kroll K, Hueber B, Manickam C, Jones RA, Smith ST, Shah SV, Varner VH, Reeves RK (2020) Characterization of rhesus macaque liver-resident CD49a+ NK cells during retrovirus infections. Front Immunol 11:1676","journal-title":"Front Immunol"},{"key":"255_CR100","volume":"12","author":"JW Rhodes","year":"2021","unstructured":"Rhodes JW, Botting RA, Bertram KM, Vine EE, Rana H, Baharlou H, Vegh P, O\u2019Neil TR, Ashhurst AS, Fletcher J et al (2021) Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells. Nat Commun 12:2147","journal-title":"Nat Commun"},{"key":"255_CR101","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.3389\/fimmu.2019.01088","volume":"10","author":"JW Rhodes","year":"2019","unstructured":"Rhodes JW, Tong O, Harman AN, Turville SG (2019) Human dendritic cell subsets, ontogeny, and impact on HIV infection. Front Immunol 10:1088","journal-title":"Front Immunol"},{"key":"255_CR102","doi-asserted-by":"crossref","first-page":"1027855","DOI":"10.3389\/fimmu.2022.1027855","volume":"13","author":"L Romero-Mart\u00edn","year":"2022","unstructured":"Romero-Mart\u00edn L, Duran-Castells C, Olivella M, Ros\u00e1s-Umbert M, Ruiz-Riol M, Sanchez J, Hartigan-O Connor D, Mothe B, Olvera \u00c0, Brander C (2022) Disruption of the HLA-E\/NKG2X axis is associated with uncontrolled HIV infections. Front Immunol 13:1027855","journal-title":"Front Immunol"},{"key":"255_CR103","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-37395-9","volume":"9","author":"Y Saeki","year":"2019","unstructured":"Saeki Y, Ishiyama K, Ishida N, Tanaka Y, Ohdan H (2019) Memory-like liver natural killer cells are responsible for Islet destruction in secondary islet transplantation. Sci Rep 9:1022","journal-title":"Sci Rep"},{"key":"255_CR104","doi-asserted-by":"crossref","first-page":"e113714","DOI":"10.15252\/embj.2023113714","volume":"42","author":"I S\u00e1nchez-Cerrillo","year":"2023","unstructured":"S\u00e1nchez-Cerrillo I, Calzada-Fraile D, Triguero-Mart\u00ednez A, Calvet-Mirabent M, Popova O, Delgado-Ar\u00e9valo C, Valdivia-Mazeyra M, Ram\u00edrez-Huesca M, de Luis EV, Bengur\u00eda A et al (2023) MICa\/b-dependent activation of natural killer cells by CD64+ inflammatory type 2 dendritic cells contributes to autoimmunity. EMBO J 42:e113714","journal-title":"EMBO J"},{"key":"255_CR105","doi-asserted-by":"crossref","first-page":"e182660","DOI":"10.1172\/jci.insight.182660","volume":"9","author":"N S\u00e1nchez-Gaona","year":"2024","unstructured":"S\u00e1nchez-Gaona N, Gallego-Cort\u00e9s A, Astorga-Gamaza A, Rall\u00f3n N, Benito JM, Ruiz-Mateos E, Curran A, Burgos J, Navarro J, Suanzes P et al (2024) NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control. JCI Insight 9:e182660","journal-title":"JCI Insight"},{"key":"255_CR106","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1128\/JVI.76.15.7812-7821.2002","volume":"76","author":"RW Sanders","year":"2002","unstructured":"Sanders RW, de Jong EC, Baldwin CE, Schuitemaker JHN, Kapsenberg ML, Berkhout B (2002) Differential transmission of human immunodeficiency virus type 1 by distinct subsets of effector dendritic cells. J Virol 76:7812\u20137821","journal-title":"J Virol"},{"key":"255_CR107","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3389\/fimmu.2018.00344","volume":"9","author":"K Schmitt","year":"2018","unstructured":"Schmitt K, Akkina R (2018) Ultra-sensitive HIV-1 latency viral outgrowth assays using humanized mice. Front Immunol 9:344","journal-title":"Front Immunol"},{"key":"255_CR108","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04669-4","volume":"21","author":"R Schober","year":"2023","unstructured":"Schober R, Brandus B, Laeremans T, Iserentant G, Rolin C, Dessilly G, Zimmer J, Moutschen M, Aerts JL, Dervillez X et al (2023) Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cure. J Transl Med 21:791","journal-title":"J Transl Med"},{"key":"255_CR109","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.immuni.2023.01.016","volume":"56","author":"IS Schuster","year":"2023","unstructured":"Schuster IS, Sng XYX, Lau CM, Powell DR, Weizman O-E, Fleming P, Neate GEG, Voigt V, Sheppard S, Maraskovsky AI et al (2023) Infection induces tissue-resident memory NK cells that safeguard tissue health. Immunity 56:531\u2013546.e6","journal-title":"Immunity"},{"key":"255_CR110","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1128\/JVI.00563-15","volume":"89","author":"K Seay","year":"2015","unstructured":"Seay K, Church C, Zheng JH, Deneroff K, Ochsenbauer C, Kappes JC, Liu B, Jeng EK, Wong HC, Goldstein H (2015) In vivo activation of human NK cells by treatment with an interleukin-15 superagonist potently inhibits acute in vivo HIV-1 infection in humanized mice. J Virol 89:6264\u20136274","journal-title":"J Virol"},{"key":"255_CR111","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.celrep.2018.11.020","volume":"25","author":"SV Shah","year":"2018","unstructured":"Shah SV, Manickam C, Ram DR, Kroll K, Itell H, Permar SR, Barouch DH, Klatt NR, Reeves RK (2018) CMV primes functional alternative signaling in adaptive \u0394g NK cells but is subverted by lentivirus infection in rhesus macaques. Cell Rep 25:2766\u20132774.e3","journal-title":"Cell Rep"},{"key":"255_CR112","doi-asserted-by":"crossref","first-page":"1192907","DOI":"10.3389\/fimmu.2023.1192907","volume":"14","author":"E Shin","year":"2023","unstructured":"Shin E, Bak SH, Park T, Kim JW, Yoon S-R, Jung H, Noh J-Y (2023) Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond. Front Immunol 14:1192907","journal-title":"Front Immunol"},{"key":"255_CR113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jiaa649","volume":"223","author":"JD Siliciano","year":"2021","unstructured":"Siliciano JD, Siliciano RF (2021) Low inducibility of latent human immunodeficiency virus type 1 proviruses as a major barrier to cure. J Infect Dis 223:13\u201321","journal-title":"J Infect Dis"},{"key":"255_CR114","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1182\/blood-2003-07-2314","volume":"104","author":"A Smed-S\u00f6rensen","year":"2004","unstructured":"Smed-S\u00f6rensen A, Lor\u00e9 K, Walther-Jallow L, Andersson J, Spetz A-L (2004) HIV-1-infected dendritic cells up-regulate cell surface markers but fail to produce IL-12 p70 in response to CD40 ligand stimulation. Blood 104:2810\u20132817","journal-title":"Blood"},{"key":"255_CR115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fcimb.2020.00208","volume":"10","author":"V Stary","year":"2020","unstructured":"Stary V, Stary G (2020) NK cell-mediated recall responses: memory-like, adaptive, or antigen-specific? Front Cell Infect Microbiol 10:208","journal-title":"Front Cell Infect Microbiol"},{"key":"255_CR116","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fcimb.2020.00038","volume":"10","author":"H Su","year":"2020","unstructured":"Su H, Sravanam S, Gorantla S, Kaminski R, Khalili K, Poluektova L, Gendelman HE, Dash PK (2020) Amplification of replication competent HIV-1 by adoptive transfer of human cells from infected humanized mice. Front Cell Infect Microbiol 10:38","journal-title":"Front Cell Infect Microbiol"},{"key":"255_CR117","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1084\/jem.20111760","volume":"209","author":"JC Sun","year":"2012","unstructured":"Sun JC, Madera S, Bezman NA, Beilke JN, Kaplan MH, Lanier LL (2012) Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J Exp Med 209:947\u2013954","journal-title":"J Exp Med"},{"key":"255_CR118","doi-asserted-by":"crossref","first-page":"e162694","DOI":"10.1172\/JCI162694","volume":"132","author":"CM Sungur","year":"2022","unstructured":"Sungur CM, Wang Q, Ozant\u00fcrk AN, Gao H, Schmitz AJ, Cella M, Yokoyama WM, Shan L (2022) Human NK cells confer protection against HIV-1 infection in humanized mice. J Clin Investig 132:e162694","journal-title":"J Clin Investig"},{"key":"255_CR119","doi-asserted-by":"crossref","first-page":"3824","DOI":"10.1182\/blood-2004-10-3880","volume":"105","author":"PH Tan","year":"2005","unstructured":"Tan PH, Beutelspacher SC, Xue S-A, Wang Y-H, Mitchell P, McAlister JC, Larkin DFP, McClure MO, Stauss HJ, Ritter MA et al (2005) Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy. Blood 105:3824\u20133832","journal-title":"Blood"},{"key":"255_CR120","doi-asserted-by":"crossref","first-page":"101302","DOI":"10.1016\/j.smim.2019.101302","volume":"42","author":"R Tang","year":"2019","unstructured":"Tang R, Rangachari M, Kuchroo VK (2019) Tim-3: a co-receptor with diverse roles in T cell exhaustion and tolerance. Semin Immunol 42:101302","journal-title":"Semin Immunol"},{"key":"255_CR121","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/v16060911","volume":"16","author":"JJ Thavarajah","year":"2024","unstructured":"Thavarajah JJ, H\u00f8nge BL, Wejse CM (2024) The use of broadly neutralizing antibodies (bNAbs) in HIV-1 treatment and prevention. Viruses 16:911","journal-title":"Viruses"},{"key":"255_CR122","doi-asserted-by":"crossref","first-page":"6374379","DOI":"10.1155\/2016\/6374379","volume":"2016","author":"R Thomas","year":"2016","unstructured":"Thomas R, Yang X (2016) NK-DC crosstalk in immunity to microbial infection. J Immunol Res 2016:6374379","journal-title":"J Immunol Res"},{"key":"255_CR123","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1089\/aid.2016.0253","volume":"33","author":"CG Thompson","year":"2017","unstructured":"Thompson CG, Gay CL, Kashuba ADM (2017) HIV persistence in gut-associated lymphoid tissues: pharmacological challenges and opportunities. AIDS Res Hum Retroviruses 33:513\u2013523","journal-title":"AIDS Res Hum Retroviruses"},{"key":"255_CR124","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/imm.13664","volume":"170","author":"E Uyangaa","year":"2023","unstructured":"Uyangaa E, Choi JY, Park SO, Byeon HW, Cho HW, Kim K, Eo SK (2023) TLR3\/TRIF pathway confers protection against herpes simplex encephalitis through NK cell activation mediated by a loop of type I IFN and IL-15 from epithelial and dendritic cells. Immunology 170:83\u2013104","journal-title":"Immunology"},{"key":"255_CR125","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.1182\/bloodadvances.2022008952","volume":"7","author":"K van der Ploeg","year":"2023","unstructured":"van der Ploeg K, Sottile R, Kontopoulos T, Shaffer BC, Papanicolaou GA, Maloy MA, Cho C, Robinson KS, Perales M-A, Le Luduec J-B et al (2023) Emergence of human CMV-induced NKG2C+NK cells is associated with CD8+T-cell recovery after allogeneic HCT. Blood Adv 7:5784\u20135798","journal-title":"Blood Adv"},{"key":"255_CR126","doi-asserted-by":"crossref","first-page":"e0112623","DOI":"10.1128\/jvi.01126-23","volume":"97","author":"J van Duijn","year":"2023","unstructured":"van Duijn J, Stieh D, Fernandez N, King D, Gilmour J, Tolboom J, Callewaert K, Willems W, Pau MG, De Rosa SC et al (2023) Mosaic HIV-1 vaccination induces anti-viral CD8+T cell functionality in the phase 1\/2a clinical trial APPROACH. J Virol 97:e0112623","journal-title":"J Virol"},{"key":"255_CR127","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1099\/vir.0.055541-0","volume":"94","author":"L Vassena","year":"2013","unstructured":"Vassena L, Giuliani E, Matusali G, Cohen \u00c9A, Doria M (2013) The human immunodeficiency virus type 1 Vpr protein upregulates PVR via activation of the ATR-mediated DNA damage response pathway. J Gen Virol 94:2664\u20132669","journal-title":"J Gen Virol"},{"key":"255_CR128","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/QAD.0000000000002488","volume":"34","author":"E Vendrame","year":"2020","unstructured":"Vendrame E, Seiler C, Ranganath T, Zhao NQ, Vergara R, Alary M, Labb\u00e9 A-C, Gu\u00e9dou F, Poudrier J, Holmes S et al (2020) TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells. AIDS 34:801\u2013813","journal-title":"AIDS"},{"key":"255_CR129","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3390\/v12020127","volume":"12","author":"MC Virgilio","year":"2020","unstructured":"Virgilio MC, Collins KL (2020) The impact of cellular proliferation on the HIV-1 reservoir. Viruses 12:127","journal-title":"Viruses"},{"key":"255_CR130","volume":"11","author":"C Wan","year":"2020","unstructured":"Wan C, Bachmann N, Mitov V, Blanquart F, C\u00e9spedes SP, Turk T, Neumann K, Beerenwinkel N, Bogojeska J, Fellay J et al (2020) Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART. Nat Commun 11:5542","journal-title":"Nat Commun"},{"key":"255_CR131","volume":"15","author":"Z Wang","year":"2018","unstructured":"Wang Z, Simonetti FR, Siliciano RF, Laird GM (2018) Measuring replication competent HIV-1: advances and challenges in defining the latent reservoir. Retrovirology 15:21","journal-title":"Retrovirology"},{"key":"255_CR132","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1186\/s13046-019-1310-0","volume":"38","author":"J Wu","year":"2019","unstructured":"Wu J, Gao F-X, Wang C, Qin M, Han F, Xu T, Hu Z, Long Y, He X-M, Deng X et al (2019) IL-6 and IL-8 secreted by tumour cells impair the function of NK cells via the STAT3 pathway in oesophageal squamous cell carcinoma. J Exp Clin Cancer Res 38:321","journal-title":"J Exp Clin Cancer Res"},{"key":"255_CR133","doi-asserted-by":"crossref","first-page":"602492","DOI":"10.3389\/fimmu.2021.602492","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, Lu X, Cheung AKL, Zhang Q, Liu Z, Li Z, Yuan L, Wang R, Liu Y, Tang B et al (2021a) Analysis of the characteristics of TIGIT-expressing CD3-CD56+NK cells in controlling different stages of HIV-1 infection. Front Immunol 12:602492","journal-title":"Front Immunol"},{"key":"255_CR134","doi-asserted-by":"crossref","first-page":"792775","DOI":"10.3389\/fimmu.2021.792775","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Zhou Y, Lu J, Chen Y-F, Hu H-Y, Xu X-Q, Fu G-F (2021b) Changes in NK cell subsets and receptor expressions in HIV-1 infected chronic patients and HIV controllers. Front Immunol 12:792775","journal-title":"Front Immunol"},{"key":"255_CR135","first-page":"157","volume":"298","author":"L Zitvogel","year":"2006","unstructured":"Zitvogel L, Terme M, Borg C, Trinchieri G (2006) Dendritic cell-NK cell cross-talk: regulation and physiopathology. Curr Top Microbiol Immunol 298:157\u2013174","journal-title":"Curr Top Microbiol Immunol"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00255-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00255-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00255-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T09:54:01Z","timestamp":1786960441000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00255-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":135,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7,11]]}},"alternative-id":["255"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00255-x","relation":{},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"27 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"11"}}